$13.52 Billion Stents Market - Global Forecast to 2027: Acquisitions and Distribution Agreements to Open an Array of Opportunities for the Market to Flourish - ResearchAndMarkets.com

The "Global Stents Market, Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The global stents market is expected to reach $13,522.8 million by 2027, growing at a mid single digit CAGR from 2020 to 2027. The market is segmented by product, material, application, end-users and geography.

Stents are the miniaturized, flexible or expandable tube like structures used to widen and establish patency of the clogged vascular or non-vascular tubular structures and to ensure steady flow of body fluids through them.

Compared to the traditional highly invasive surgical repair procedures, the current minimally invasive transcatheter therapeutic procedures with highly efficient, technologically advanced stent products assure patients and healthcare providers with improved efficiency, effectiveness and quicker restoration of the narrowed vessel's or duct's natural function.

Increased utilization of the various stent products for the numerous and varied types of vascular and non-vascular obstructive conditions and cerebral aneurysm among the patients, elevating inclination of the value centric global patient pool towards the minimally invasive, technologically advanced stent products with better therapeutic outcomes and the need to rapidly mitigate the clinical manifestations associated with blocked vascular and non-vascular hollow organs or weakened vascular bed, reduce hospitalization duration and ease and improve the patient's condition quickly through efficient and safer interventional products are fuelling the stents global market.

The stents global market is consolidated with few companies dominating and occupying major share of the market. Some of the leading players in stents market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Cook Medical LLC (U.S.), Cardinal Health Inc. (U.S.), Becton, Dickinson and company (U.S.), B. Braun Melsungen AG (Germany), Biotronik SE & Co. KG (Germany), Blue Sail Medical Co. Ltd. (Biosensors International Pte. Ltd.) (China) and others.

Drivers and Opportunities

• Escalating Prevalence of Vascular and Non-Vascular Stenotic Diseases and Cerebral Aneurysm
• Elevating Inclination Towards Minimally Invasive Therapeutic Approaches
• The Trend of Coronary Stent Price Slashing and Increasing Competitiveness of Domestic Players in APAC Countries
• Emergence of Technologically Advanced Products
• Escalating Geriatric Population and Feasibility of Drug Eluting Stents in Them
• Acquisitions and Distribution Agreements to Open an Array of Opportunities for the Market to Flourish
• Favourable Reimbursement Policies Escalating Stent Technology Diffusion in Developed Nations

Restraints and Threats

• Stringent Regulatory Bodies Guiding Stent Manufacturers
• The Threat of Commercialized Stent Recalls
• Lack of Skilled, Experienced and Trained Healthcare Professionals
• Adverse Effects of Stents
• Concerns Over Irrational Stenting and Under-Performance of Stents in Complex Stenotic Diseases or Lesions

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis

4 Stents Global Market, by Product

5 Stents Global Market, by Material

6 Stents Global Market, by Application

7 Stents Global Market, by End-users

8 Regional Analysis

9 Competitive Landscape

10 Major Companies

• Abbott Laboratories
• Braun Melsungen AG
• Becton, Dickinson and Company
• Biotronik SE & Co. KG
• Blue Sail Medical Co. Ltd. (Biosensors International Pte. Ltd.)
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical LLC
• Medtronic plc
• Terumo Corporation

Companies Mentioned

• Abbott Laboratories
• Abbvie Inc.
• Acandis GmbH
• Accura Medizintechnik GmbH
• Allium Ltd.
• Alvimedica
• AndraTec GmbH
• Arterius Limited
• B. Braun Melsungen AG
• B.Braun Melsungen AG
• Balt Extrusion
• Balton Sp. z o.o.
• Becton, Dickinson and Company
• Bentley InnoMed GmbH
• Bess AG
• Bioteque Corporation
• Biotronik SE & Co. KG
• Blue Sail Medical Co. Ltd.
• Boston Scientific Corporation
• Cardinal Health Inc.
• CeloNova BioSciences, Inc.
• Conmed Corporation
• Cook Medical LLC
• Disa Vascular
• Dispomedica GmbH
• Elixir Medical Corporation
• ELLA - CS, s.r.o
• Endocor GmbH
• EndoGI Medical
• Eucatech AG
• EuroCor Tech GmbH
• GENOSS Co. Ltd.
• Glaukos Corporation
• Hexacath International
• HydrUStent SA
• InspireMD
• Ivantis Inc.
• iVascular S.L.U.
• Kyoto Medical Planning Co. Ltd.
• Lepu Medical Technology
• M.I.TECH Co. Ltd.
• Med pro Medical B.V.
• Medas Inc.
• Medicut Stent Technology GmbH
• Medinol Ltd.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• Merit Medical Systems Inc.
• Merlin MD Pte. Ltd.
• Micell Technologies, Inc.
• Micro Science Medical AG
• Micro-Tech
• Microport Scientific Corporation
• Nanostent
• Numed Inc.
• Olympus Corporation
• Optimed Medizinische Instrumente GmbH
• Opto Circuits
• OrbusNeich Medical Company Limited
• Palex Medical SA
• Phenox GmbH
• Plus medica Nordic AB
• PNN Medical A/S
• Poseidon Medical Inc.
• Q3 Medical Devices Ltd.
• Relisys Medical Devices Limited
• REVA Medical Inc.
• Rontis AG
• Sahajanand Medical Technologies Pvt. Ltd.
• Scitech Produtos Medicos SA
• Silk Road Medical Inc.
• Stening Srl
• Svelte Medical Systems Inc.
• Synlas GmbH & Co. KG
• Taewoong Medical Co. Ltd.
• Terumo Corporation
• Thoracent, Inc.
• Translumina Therapeutics
• USM Healthcare Medical Devices Factory JSC
• Vygon SA
• W. L. Gore & Associates, Inc.
• Wellinq Holding B.V.
• Zhejiang Chuangxiang Medical Technology Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/llv67k

View source version on businesswire.com: https://www.businesswire.com/news/home/20210304005463/en/